WAM
AMPH icon

Wealthspire Advisors (Maryland)’s Amphastar Pharmaceuticals AMPH Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-103
Closed -$2K – 528
2019
Q1 		$2K Hold
103
– – ﹤0.01% 2113
2018
Q4 		$2K Buy
103
+97
+1,617% +$1.91K ﹤0.01% 2045
2018
Q3 		$0 Hold
6
– – ﹤0.01% 2376
2018
Q2 		$0 Hold
6
– – ﹤0.01% 2419
2018
Q1 		$0 Hold
6
– – ﹤0.01% 2487
2017
Q4 		$0 Hold
6
– – ﹤0.01% 2428
2017
Q3 		$0 Buy
+6
New +$99 ﹤0.01% 2239

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s AMPH Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2019, closing a stake of 103 shares — an estimated $2K sold.

Wealthspire Advisors (Maryland) first reported a position in AMPH in Q3 2017 and held it in 7 quarters. The position peaked at $2K in Q1 2019. 133 funds tracked by Wall St. Rank hold AMPH as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Amphastar Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 103 Amphastar Pharmaceuticals shares in Q2 2019, an estimated $2K.
  • Wealthspire Advisors (Maryland) first reported a position in Amphastar Pharmaceuticals in Q3 2017 and held it in 7 quarters.
  • Wealthspire Advisors (Maryland)'s Amphastar Pharmaceuticals position peaked at $2K in Q1 2019.
  • 133 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.